Logotype for Chart Industries Inc

Chart Industries (GTLS) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Chart Industries Inc

Q3 2024 earnings summary

8 Jul, 2026

Executive summary

  • Q3 2024 sales reached $1.06 billion, up 22.4% year-over-year, with all segments reporting sales and margin growth; orders rose 5.4% to $1.17 billion, and gross margin improved to 34.1% due to cost synergies from the Howden acquisition.

  • Adjusted EBITDA was $260.7 million (24.5% margin), up 39.3% year-over-year; adjusted EPS was $2.18, impacted by FX and tax rate changes.

  • Free cash flow reached $174.6 million, supporting net leverage reduction to 3.04, with net cash from operations at $200.7 million.

  • Backlog increased to $4.54 billion, with a $23 billion commercial pipeline and $1.95 billion in customer commitments not yet in backlog.

  • Notable commercial wins included major LNG and hydrogen projects, with all segments contributing to improved profitability.

Financial highlights

  • Q3 2024 sales: $1.06 billion (+22.4% YoY); gross margin: 34.1% (+350 bps YoY); adjusted operating income: $236 million (22.2% margin); adjusted EBITDA: $260.7 million (24.5% margin).

  • Reported operating income: $178.5 million (16.8% margin); reported EBITDA: $248.4 million (23.4% margin); adjusted EPS: $2.18; reported EPS: $1.34.

  • Free cash flow: $174.6 million; net cash from operations: $200.7 million; CapEx: $26.1 million.

  • Net leverage ratio: 3.04 at September 30, 2024.

  • Book-to-bill ratio: 1.10; backlog up 9.5% year-over-year.

Outlook and guidance

  • FY 2024 sales outlook: $4.2–$4.3 billion (+18–21% YoY); adjusted EBITDA: $1.015–$1.045 billion; adjusted EPS: ~$9; free cash flow: ~$400 million.

  • FY 2025 sales guidance: $4.65–$4.85 billion; adjusted EBITDA: $1.175–$1.225 billion; adjusted EPS: $12–$13; free cash flow: $550–$600 million; net leverage target: 2.0–2.5 by end of 2025.

  • Strong backlog coverage for 2025, with 61% of backlog scheduled to convert in the next 12 months.

  • Q4 2024 expected to see sequential sales growth of 10–15%, with continued strength in HTS, specialty, and RSL segments.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more